Identification of serum microRNA profiles in colon cancer
- PMID: 23558896
- PMCID: PMC3668463
- DOI: 10.1038/bjc.2013.121
Identification of serum microRNA profiles in colon cancer
Abstract
Background: microRNAs (miRNAs) exist in blood in an apparently stable form. We have explored whether serum miRNAs can be used as non-invasive early biomarkers of colon cancer.
Methods: Serum samples from 30 patients with colon cancer stage IV and 10 healthy controls were examined for the expression of 375 cancer-relevant miRNAs. Based on the miRNA profile in this study, 34 selected miRNAs were measured in serum from 40 patients with stage I-II colon cancer and from 10 additional controls.
Results: Twenty miRNAs were differentially expressed in serum from stage IV patients compared with controls (P<0.01). Unsupervised clustering revealed four subgroups; one corresponding mostly to the control group and the three others to the patient groups. Of the 34 miRNAs measured in the follow-up study of stage I-II patients, 21 showed concordant expression between stage IV and stage I-II patient. Based on the profiles of these 21 miRNAs, a supervised linear regression analysis (Partial Least Squares Regression) was performed. Using this model we correctly assigned stage I-II colon cancer patients based on miRNA profiles of stage IV patients.
Conclusion: Serum miRNA expression profiling may be utilised in early detection of colon cancer.
Figures
Similar articles
-
Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.Cancer Genomics Proteomics. 2013 May-Jun;10(3):93-113. Cancer Genomics Proteomics. 2013. PMID: 23741026
-
Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.Lancet Oncol. 2013 Dec;14(13):1295-306. doi: 10.1016/S1470-2045(13)70491-1. Epub 2013 Nov 13. Lancet Oncol. 2013. PMID: 24239208
-
Novel circulating microRNAs expression profile in colon cancer: a pilot study.Eur J Med Res. 2017 Nov 29;22(1):51. doi: 10.1186/s40001-017-0294-5. Eur J Med Res. 2017. PMID: 29187262 Free PMC article.
-
Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.Carcinogenesis. 2016 Oct;37(10):941-950. doi: 10.1093/carcin/bgw078. Epub 2016 Aug 1. Carcinogenesis. 2016. PMID: 27485599
-
MicroRNAs and inflammation in the pathogenesis and progression of colon cancer.Dig Dis. 2012;30 Suppl 2(Suppl 2):9-15. doi: 10.1159/000341882. Epub 2012 Nov 23. Dig Dis. 2012. PMID: 23207927 Free PMC article. Review.
Cited by
-
Plasma exosomal microRNA-125b as a monitoring biomarker of resistance to mFOLFOX6-based chemotherapy in advanced and recurrent colorectal cancer patients.Mol Clin Oncol. 2019 Oct;11(4):416-424. doi: 10.3892/mco.2019.1911. Epub 2019 Aug 14. Mol Clin Oncol. 2019. PMID: 31497299 Free PMC article.
-
A Tetra-Panel of Serum Circulating miRNAs for the Diagnosis of the Four Most Prevalent Tumor Types.Int J Mol Sci. 2020 Apr 16;21(8):2783. doi: 10.3390/ijms21082783. Int J Mol Sci. 2020. PMID: 32316350 Free PMC article.
-
Evaluation of miR-720 prognostic significance in patients with colorectal cancer.Tumour Biol. 2015 Feb;36(2):719-27. doi: 10.1007/s13277-014-2697-z. Epub 2014 Oct 7. Tumour Biol. 2015. PMID: 25286763
-
Serum MicroRNA profile in patients with colon adenomas or cancer.BMC Med Genomics. 2017 Apr 20;10(1):23. doi: 10.1186/s12920-017-0260-7. BMC Med Genomics. 2017. PMID: 28427387 Free PMC article.
-
KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population.Oncol Lett. 2017 May;13(5):3608-3616. doi: 10.3892/ol.2017.5889. Epub 2017 Mar 22. Oncol Lett. 2017. PMID: 28521461 Free PMC article.
References
-
- Babashah S, Soleimani M. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer. 2011;47 (8:1127–1137. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources